To maintain safe vascular access for hemodialysis is one of the main o
bjectives in nephrology. Nowadays, autologous or heterologous arteriov
enous fistulas are the first choice, and to prolong their survival is
a priority in the nephrologist's daily clinical practice. The developm
ent of transluminal percutaneous angioplasty allows us to treat fistul
a stenosis and to prevent the development of trombosis. The aim of thi
s study is to review our experience in the early diagnosis oi fistula
stenosis and its treatment with transluminal percutaneous angioplasty
through a period of 21 months highlighting the patency rates obtained
in this interval of time. Twenty-nine angioplasty procedures were perf
ormed on twenty fistulas of nineteen patients (ten male, nine female).
Fourteen fistulas were autologous and six heterologous. By maintainin
g close hemodynamic monitoring we were able to diagnose the stenosis b
ecause of a decrease in blood flow in a 52% of cases, an increase in v
enous pressure in a 31% and because of recirculation in the rest (17%)
. The clinical suspicion was confirmed in all cases, using doppler stu
dies and angiography in 73% of cases and angiography alone in the rest
angioplasty was then performed. A median of 1,48 +/- 0,82 procedures
were performed per fistula (minimum 1, maximum 4). Two cases required
a stent placement because or frequent re-stenosis. With the Kaplan-Mei
er method, we have calculated the patency rates of the fistulas after
being dilated by angioplasty. The primary radiologic patency rate of a
dialysis shunt after one angioplasty procedure was 67% at 21 months,
increasing to 80% ii the fistula was dilated as many times as needed b
ecause of re-stenosis (secondary radiologic patency rate). Consequentl
y, we conclude that transluminal percutaneous angioplasty is a useful
method to prolong the survival of arteriovenous shunts if it is perfor
med son after the hemodynamic monitoring indicates the development of
a stenosis.